Immuneering has more than a decade of experience providing critical work for major pharmaceutical companies helping them characterize drug mechanisms, identify targets, pinpoint biomarkers and more. Deploying in cloud-based or local environments, Immuneering analyzes clinical, laboratory and biobank data ranging from single-analyte to -omic level transcript, protein, genomics assays. Efficient and reusable code enables diving into biological signal, and we have spent years understanding how and why successful drugs work.
Immuneering is focused on rigorous and robust analysis which we maintain in analyzing gene expression and bioinformatic data. We deliver an iterative, feedback-driven approach and our methods are transparent with frequent interim updates to present results in meetings and/or written into reports showcase actionable insights. This has been showcased through multiple presentations, textbook chapters, patents and peer-reviewed publications. Over the past 12 years, Immuneering has worked with Janssen, Alexion, UCB, Rhythm, Teva, BMS, and Biogen to help their partners make the most of their data.